Biomarker Assessment of Homologous Recombination Deficiency in Epithelial Ovarian Cancer: Association With Progression-Free Survival After Surgery

Identifying BRCA mutations and homologous recombination deficiency (HRD) is the key to choosing patients for poly (ADP-ribose) polymerase inhibitor (PARPi) therapy. At present, a large amount of research focuses on the application of HRD detection in ovarian cancer. However, few studies have discuss...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Huan, Li, Linhong, Huang, Jimiao, Ma, Zhiming, Li, Hongping, Chen, Jian, Zheng, Xiangqin, Chen, Jingjing, He, Haixin, Song, Jianrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234295/
https://www.ncbi.nlm.nih.gov/pubmed/35769916
http://dx.doi.org/10.3389/fmolb.2022.906922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234295/
https://www.ncbi.nlm.nih.gov/pubmed/35769916
http://dx.doi.org/10.3389/fmolb.2022.906922

Ejemplares similares